Chiesi USA, Inc. recalls CUROSURF (poractant alfa), 240 mg, Intratracheal Suspension, 3L Single-dose-Vial, Rx only, Chiesi USA, Inc, Cary, NC 275
Recalled April 1, 2026 · FDA recall D-0402-2026 · Chiesi USA
Hazard
Lack of Assurance of Sterility · FDA Class II
Units
7,235 vials
Sold at
Nationwide within the United States
Description
Lack of Assurance of Sterility
Product
CUROSURF (poractant alfa), 240 mg, Intratracheal Suspension, 3L Single-dose-Vial, Rx only, Chiesi USA, Inc, Cary, NC 27518, NDC 10122-510-03.
Manufacturer(s)
Chiesi USA, Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →